In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
In October 2019, a class-action lawsuit was filed against Sanofi-Aventis U.S., Sanofi US Services, Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals for allegedly failing to disclose that the over-the-counter heartburn medication…
Kenan Thompson Wants To Help You Find Your Next Car
FDA targets companies selling eye drops illegally marketed to treat conditions like pink eye.
Be wary of anyone who says there’s big money to be made as a life coach.
Seven things TINA.org learned from attending MLM’s three-day event virtually.
Steve Toloken , Plastic News